Sign up to save your podcasts
Or
Share 1. Is Ozempic really useful for weight loss?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
1. Is Ozempic really useful for weight loss?
In this episode find a comparative analysis of three studies on semaglutide for weight loss and recommendations for clinical practice. This comparative analysis evaluates three key studies on the use of semaglutide for weight loss. Each study examined the efficacy and safety of semaglutide.
Follow us on social media!
References:
-Paper #1: Ghusn W, De la Rosa A, Sacoto D, Cifuentes L, Campos A, Feris F, Hurtado MD, Acosta A. Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity. JAMA Network Open. 2022 Sep 1;5(9):e2231982-.
Link: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2796491
-Paper #2: Wilding JP, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MT, Wadden TA, Wharton S. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021 Mar 18;384(11):989-1002.
Link: https://pubmed.ncbi.nlm.nih.gov/33567185/
-Paper #3: Gao X, Hua X, Wang X, Xu W, Zhang Y, Shi C, Gu M. Efficacy and safety of semaglutide on weight loss in obese or overweight patients without diabetes: a systematic review and meta-analysis of randomized controlled trials. Frontiers in pharmacology. 2022 Sep 14;13:935823.
Link: https://www.frontiersin.org/articles/10.3389/fphar.2022.935823/full
View all episodes
By Agora ProjectIn this episode find a comparative analysis of three studies on semaglutide for weight loss and recommendations for clinical practice. This comparative analysis evaluates three key studies on the use of semaglutide for weight loss. Each study examined the efficacy and safety of semaglutide.
Follow us on social media!
References:
-Paper #1: Ghusn W, De la Rosa A, Sacoto D, Cifuentes L, Campos A, Feris F, Hurtado MD, Acosta A. Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity. JAMA Network Open. 2022 Sep 1;5(9):e2231982-.
Link: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2796491
-Paper #2: Wilding JP, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MT, Wadden TA, Wharton S. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021 Mar 18;384(11):989-1002.
Link: https://pubmed.ncbi.nlm.nih.gov/33567185/
-Paper #3: Gao X, Hua X, Wang X, Xu W, Zhang Y, Shi C, Gu M. Efficacy and safety of semaglutide on weight loss in obese or overweight patients without diabetes: a systematic review and meta-analysis of randomized controlled trials. Frontiers in pharmacology. 2022 Sep 14;13:935823.
Link: https://www.frontiersin.org/articles/10.3389/fphar.2022.935823/full